Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Product Type & Application In 2021, the global microneedle drug delivery systems market size was valued at USD 5.71 billion. The microneedle drug delivery systems market is forecasted to grow up to USD 10.14 billion in 2030, with an estimated CAGR of 6.5%. The North American region dominated the market by accounting for over 40% of the total market share in the world. Microneedles are the devices that are used in the delivery of pre-treatment in pore formation to the skin. These microneedles penetrate the skin to create a passage for drug transportation through the human body. Market Drivers - Rising Prevalence of Obesity, increase in demand for self-administered medicine solutions, Growing Investment for Healthcare Facilities The rise in the overweight and obese population globally is significant in increasing the microneedle drug delivery systems market's size. According to the WHO, 39% of the world's population was overweight, and 13% of the total population was obese in 2016. There are increasing numbers of patients who are taking a proactive approach towards managing their health. Microneedle systems enable patients to self-administer medications, which can improve treatment adherence and lead to better overall health outcomes. The rising rate of chronic illnesses like diabetes and heart disease, which require long-term medication use, highlights the need for self-care practices. Patients who engage in self-care are better equipped to manage these illnesses. As a result, there will be a significant increase in demand for self-administered medicine solutions such as microneedles as patients become more involved in their healthcare. According to a 2021 report published by the National Center for Chronic Disease Prevention & Health Promotion (NCCDPHP), self-management education and support (SMES) programs are becoming increasingly popular in the United States. The report shows that the number of adults participating in these programs increased by 37% between 2017 and 2019. Moreover, the products that are currently assisting the market's growth are microneedle patch, hydrogel microneedle, silicon microneedle, metal microneedles, polymer microneedles, ceramic microneedles, oligonucleotide delivery, coated microneedles, dissolving microneedles, and hollow microneedles. Microneedles are currently used for medical applications such as vaccine therapy, peptide delivery, hormone delivery, lidocaine delivery, pain therapy, ocular delivery, and cancer therapy. One current product is CIT-8 (collagen induction therapy). Microneedles can also be expanded into the cosmetics industry, with the C-8 (Cosmetic type) being a prime example. Restraints Strict legal requirements for authorization make it challenging for players to enter the microneedle drug delivery systems industry, posing a significant obstacle to its expansion and wide utilization. Furthermore, accessibility is restricted by microneedle devices' high research and manufacturing costs, particularly in environments with limited resources. Further obstacles to the broad use of microneedle drug delivery systems include consumer acceptability, competition from alternative drug delivery technologies, and insufficient reimbursement guidelines. Opportunities - Upsurge in the Private-public Funding for Targeted Research, Rising Product Innovations and Developments, and Newer Applications Due to the collaboration of public and private sectors for targeted research in developing countries and the presence of highly improved technologies, a tremendous opportunity to improve the overall market's growth in the future can be created. The rising costs in the research and development activities for medical instruments and devices, especially in the developed and developing countries, will create better market opportunities in the future. In addition, R&D focused on reducing obesity will also create more significant market opportunities. Moreover, the implementation of newer and improved technologies can help the market to grow further in the future. Other than the currently marketed products of transdermal drug delivery system, the use of nanotechnology in drug delivery, microneedles for drug delivery via the gastrointestinal tract, microneedle transdermal drug delivery, transdermal microneedles for drug delivery applications, transdermal microneedles for drug delivery applications, nanoparticle drug delivery, Solid microneedle, Hydrogel microneedle, 3m Microneedle Drug Delivery, Microneedle array, MS-4, MicroHyala, microstructured transdermal systems and microneedle drug delivery systems can augment the growth of the market share further in the upcoming years. Market Analysis Of Different Segments Covered in the Report Based on Type Solid Hollow Dissolving Coated Others Based on Material Silicon Metal Polymer Others Based on Application Dermatology Drug Delivery Pain Management Cancer Therapy Vaccine Delivery Others Regional Coverage Analysis North America United States of America Canada Europe United Kingdom Germany France Italy Spain Asia-Pacific China Japan India Thailand South Korea Latin America Brazil Mexico Argentina Colombia Middle East and Africa Saudi Arabia South Africa United Arab Emirates Segments Analysis & Insights On the basis of Type, the hollow microneedle segment held the largest market position with 26% of the revenue share in 2020. A hollow MN can be used to identify various illnesses such as diabetes, Alzheimer's, and cancer. The capacity of a hollow microneedle to handle drug solutions is higher than that of a solid microneedle. This type of needle can efficiently deliver medication to the viable dermis or epidermis, even for high molecular weight substances. On the basis of Material, the metal microneedle segment dominated the market with significant revenue share of 27% in the year 2020. One of the benefits of metal MN is its good mechanical strength, ease of fabrication, affordability, and established safety records in FDA-approved medical devices. Titanium, nickel, and stainless steel are other commonly utilized metals. Based on application, the vaccine delivery segment is anticipated to expand quickly at a CAGR of 6.3% from 2020 to 2030. Due to the increased awareness of vaccination by the population, scientists can develop new vaccine administration methods. Based on the region, North America accounted for the most significant share of market revenue, with over 40% in 2020. Due to the governments in North America forming different projects and reducing R&D costs, the North American market for microneedles has skyrocketed. Global Microneedle Drug Delivery Systems Market Competitive Landscape Analysis Competitors in this market are evaluated based on company financials, revenue generated, market potential, new market investment, investment in R&D, and global presence. The key players in this market are: AdminMed nanoBioSciences LLC Becton, Dickinson and Company Zosano Pharma Corporation Raphas Co. Ltd. Nanopass Technologies Ltd. Corium International, Inc. (Gurnet Point Capital) Valeritas, Inc. (Zealand Pharma) Nitto Denko Corporation Endoderma Ltd. Innoture Medical Technology Limited Microneedle Drug Delivery Systems Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 5.71 billion The revenue forecast in 2030 USD 10.08 billion Growth rate CAGR of approximately 6.5% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation Based on Type, Based on Material, Based on Application, Based on Region Based on Type Solid, Hollow, Dissolving, Coated, Others Based on Material Silicon, Metal, Polymer, Others Based on Application Dermatology, Drug Delivery, Pain Management, Cancer Therapy, Vaccine Delivery, Others By Region North America, Europe, Latin America, Middle East and Africa Country Scope United States of America, Mexico, United Arab Emirates, United Kingdom, Germany, France, Canada, China, India, Japan, South Korea, Brazil, Argentina, Saudi Arabia, South Africa Company Usability Profiles AdminMed nanoBioSciences LLC, Becton, Dickinson and Company, Zosano Pharma Corporation, Raphas Co. Ltd., Nanopass Technologies Ltd., Corium International, Inc. (Gurnet Point Capital), Valeritas, Inc. (Zealand Pharma), Nitto Denko Corporation, Endoderma Ltd., Innoture Medical Technology Limited Recent Developments In April 2023, A team of researchers from the United States and Singapore developed the world's first plant-drug delivery method using microneedles. This technique can be used to deliver precise amounts of regulated agrochemicals to specific plant tissues for research purposes. In the future, precision agriculture could use it to enhance crop quality and control diseases in the field. The Singapore-MIT Alliance for Research and Technology's (SMART) interdisciplinary research team, Disruptive and Sustainable Technologies for Agricultural Precision (DiSTAP), along with their partners from Temasek Life Sciences Laboratory (TLL) and MIT, are leading this groundbreaking work. In November 2023, Daewoong Pharmaceutical declared that it would start working on a microneedle patch that would include analogues of GLP-1 (glucagon-like peptide-1) in order to treat obesity on a large scale. Compared to conventional obesity treatments, the ultra-small 1cm2 patch that is applied to the arm or belly using microneedle technology is a substantially more convenient way for users to be treated. Daewoong Pharmaceutical plans to begin Phase 1 clinical trials this year, with the drug expected to be available by 2028. In July 2023, the commercial specialty pharmaceutical company PharmaTher Holdings Ltd announced the successful completion of a research study in which they evaluated PharmaPatchTM, a proprietary microneedle patch, in delivering N, N-dimethyltryptamine (“DMT”). The research investigation was carried out in collaboration with the Terasaki Institute for Biomedical Innovation or "Terasaki." The goal of the research project was to create a workable prototype of the PharmaPatchTM for transdermal administration of DMT to potentially overcome issues with oral and intravenous doses. Various Microneedle Drug Delivery Systems Devices that Key Market Leaders Developed: Name of the Product Function Key Players MicroHyala Treatment of age spots, acne and anti-ageing cosmetic products CosMED Pharmaceutical Co. Ltd. Soluvia Intradermal Vaccination Sanofi Pasteur Europe MF-8 type Treatment of Scars Dermaroller MS-4 Treatment of Acne Scars Dermaroller LiteClear Treatment of acne and skin blemishes Nanomed Skincare h-patch Delivery of drugs in subcutaneous tissue Valeritas Microstructured Transdermal System Delivery of biologics and other small molecules 3M Frequently Asked Question About This Report How big is the microneedle drug delivery systems market size? The global microneedle drug delivery systems market size was $5.71 billion in 2021 and is predicted to reach $10.08 billion by 2030, with a CAGR of 6.5%. What are the key drivers in the market? The main factors that contribute to the growth of the market are the rising prevalence of obesity, R&D proficiencies, and the global investment in healthcare facilities. What is the microneedle drug delivery systems market growth? The global microneedle drug delivery systems market is expected to grow at a compound annual growth rate (CAGR) of 6.5% from 2021 to 2030 to reach USD $ 10.08 billion by 2030. Which material type has captured the most market share globally? The metallic material has captured the most market share globally, with more than 27% in 2021. Which region has the highest revenue? North America has the highest revenue, with more than 40%. . 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at Market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Microneedle Drug Delivery Systems Market 4.2.1 Market, 2021 – 2030 (USD Million) 4.3 Regional Analysis 4.3.1 Market, by region, 2021 - 2030 (USD Million) 4.4 By Type Analysis 4.4.1 Market, By Type, 2021 - 2030 (USD Million) 4.5 By Material Analysis 4.5.1 Market, By Material, 2021 - 2030 (USD Million) 4.6 By Application Analysis 4.6.1 Market, By Application, 2021 - 2030 (USD Million) 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. By Application Analysis 5.11.1. Trends in Application (2014-2021) 5.11.2. Trends in Application (2021-2030) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product Type 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Solid 7.3.1. Solid Market, 2021 - 2030 (USD Million) 7.4. Hollow 7.4.1. Hollow Market, 2021 - 2030 (USD Million) 7.5. Dissolving 7.5.1. Dissolving Market, 2021 - 2030 (USD Million) 7.6. Coated 7.6.1. Coated Market, 2021 - 2030 (USD Million) 7.7. Others 7.7.1. Others Market, 2021 - 2030 (USD Million) 8. Market: By Material Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Silicon 8.3.1. Silicon Market, 2021 - 2030 (USD Million) 8.4. Metal 8.4.1. Metal Market, 2021 - 2030 (USD Million) 8.4. Polymer 8.4.1. Polymer Market, 2021 - 2030 (USD Million) 8.5. Other 8.5.1. Other Market, 2021 - 2030 (USD Million) 9. Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Dermatology 9.3.1. Dermatology Market, 2021 - 2030 (USD Million) 9.4. Drug Delivery 9.4.1. Drug Delivery Market, 2021 - 2030 (USD Million) 9.5. Pain Management 9.5.1. Pain Management Market, 2021 - 2030 (USD Million) 9.6. Cancer Therapy 9.6.1. Cancer Therapy Market, 2021 - 2030 (USD Million) 9.7. Vaccine Delivery 9.7.1. Vaccine Delivery Market, 2021 - 2030 (USD Million) 9.8. Other 9.8.1. Other Market, 2021 - 2030 (USD Million) 10. Market: Regional Outlook 10.1 North America 10.1.1. North America Market, by By Type, 2021 - 2030 (USD Million) 10.1.2. North America Market, by By Material, 2021 - 2030 (USD Million) 10.1.3. North America Market, by Application, 2021 - 2030 (USD Million) 10.1.4. North America Market, by Country, 2021 - 2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. Market, by By Type, 2021 - 2030 (USD Million) 10.1.4.1.2. U.S. Market, by By Material, 2021 - 2030 (USD Million) 10.1.4.1.3. U.S. Market, by Application, 2021 - 2030 (USD Million) 10.1.4.2. Canada 10.1.4.2.1. Canada Market, by By Type, 2021 - 2030 (USD Million) 10.1.4.2.2. Canada Market, by By Material, 2021 - 2030 (USD Million) 10.1.4.2.3. Canada Market, by Application, 2021 - 2030 (USD Million) 10.2. Europe 10.2.1. Europe Market, by By Type, 2021 - 2030 (USD Million) 10.2.2. Europe Market, by By Material, 2021 - 2030 (USD Million) 10.2.3. Europe Market, by Application, 2021 - 2030 (USD Million) 10.2.4. Europe Market, by country, 2021 - 2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. Market, by By Type, 2021 - 2030 (USD Million) 10.2.4.1.2. U.K. Market, by By Material, 2021 - 2030 (USD Million) 10.2.4.1.3. U.K. Market, by Application, 2021 - 2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany Market, by By Type, 2021 - 2030 (USD Million) 10.2.4.2.2. Germany Market, by By Material, 2021 - 2030 (USD Million) 10.2.4.2.3. Germany Market, by Application, 2021 - 2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France Market, by By Type, 2021 - 2030 (USD Million) 10.2.4.3.2. France Market, by By Material, 2021 - 2030 (USD Million) 10.2.4.3.3. France Market, by Application, 2021 - 2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe Market, by By Type, 2021 - 2030 (USD Million) 10.2.4.4.2. Rest of Europe Market, by By Material, 2021 - 2030 (USD Million) 10.2.4.4.3. Rest of Europe Market, by Application, 2021 - 2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific Market, by By Type, 2021 - 2030 (USD Million) 10.3.2. Asia Pacific Market, by By Material, 2021 - 2030 (USD Million) 10.3.3. Asia Pacific Market, by Application, 2021 - 2030 (USD Million) 10.3.4. Asia Pacific Market, by country, 2021 - 2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China Market, by By Type, 2021 - 2030 (USD Million) 10.3.4.1.2. China Market, by By Material, 2021 - 2030 (USD Million) 10.3.4.1.3. China Market, by Application, 2021 - 2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India Market, by By Type, 2021 - 2030 (USD Million) 10.3.4.2.2. India Market, by By Material, 2021 - 2030 (USD Million) 10.3.4.2.3. India Market, by Application, 2021 - 2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan Market, by By Type, 2021 - 2030 (USD Million) 10.3.4.3.2. Japan Market, by By Material, 2021 - 2030 (USD Million) 10.3.4.3.3. Japan Market, by Application, 2021 - 2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea Market, by By Type, 2021 - 2030 (USD Million) 10.3.4.4.2. South Korea Market, by By Material, 2021 - 2030 (USD Million) 10.3.4.4.3. South Korea Market, by Application, 2021 - 2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC Market, by By Type, 2021 - 2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC Market, by By Material, 2021 - 2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC Market, by Application, 2021 - 2030 (USD Million) 10.4. Latin America 10.4.1. Latin America Market, by By Type, 2021 - 2030 (USD Million) 10.4.2. Latin America Market, by By Material, 2021 - 2030 (USD Million) 10.4.3. Latin America Market, by Application, 2021 - 2030 (USD Million) 10.4.4. Latin America Market, by country, 2021 - 2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil Market, by By Type, 2021 - 2030 (USD Million) 10.4.4.1.2. Brazil Market, by By Material, 2021 - 2030 (USD Million) 10.4.4.1.3. Brazil Market, by Application, 2021 - 2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico Market, by By Type, 2021 - 2030 (USD Million) 10.4.4.2.2. Mexico Market, by By Material, 2021 - 2030 (USD Million) 10.4.4.2.3. Mexico Market, by Application, 2021 - 2030 (USD Million) 10.4.4.3. Rest of the Latin America 10.4.4.3.1. Rest of the Latin America Market, by By Type, 2021 - 2030 (USD Million) 10.4.4.3.2. Rest of the Latin America Market, by By Material, 2021 - 2030 (USD Million) 10.4.4.3.3. Rest of the Latin America Market, by Application, 2021 - 2030 (USD Million) 10.5. MEA 10.5.1. MEA Market, by By Type, 2021 - 2030 (USD Million) 10.5.2. MEA Market, by By Material, 2021 - 2030 (USD Million) 10.5.3. MEA Market, by Application, 2021 - 2030 (USD Million) 10.5.4. MEA Market, by Region, 2021 - 2030 (USD Million) 11. Competitive Landscape 11.1 AdminMed nanoBioSciences LLC 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. Product Portfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. BECTON, DICKINSON AND COMPANY 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. Zosano Pharma Corporation 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. RAPHAS CO. LTD 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. NANOPASS TECHNOLOGIES LTD 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. Corium International, Inc. (Gurnet Point Capital) 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. Valeritas, Inc. (Zealand Pharma) 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development 11.8. Nitto Denko Corporation 11.8.1. Company overview 11.8.2. Financial performance 11.8.3. Product Portfolio Analysis 11.8.4. Business Strategy & Recent Development 11.9. Endoderma Ltd. 11.9.1. Company overview 11.9.2. Financial performance 11.9.3. Product Portfolio Analysis 11.9.4. Business Strategy & Recent Development 11.10. Innoture Medical Technology Limited 11.10.1. Company overview 11.10.2. Financial performance 11.10.3. Product Portfolio Analysis 11.10.4. Business Strategy & Recent Development List of Tables (55 Tables) TABLE 1. MARKET, By Type, 2021-2030 (USD Million) TABLE 2. MARKET FOR Solid, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Hollow, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET FOR Dissolving, BY REGION, 2021-2030 (USD Million) TABLE 5. MARKET FOR Coated, BY REGION, 2021-2030 (USD Million) TABLE 6. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET, By Material, 2021-2030 (USD Million) TABLE 8. MARKET FOR Silicon, BY REGION, 2021-2030 (USD Million) TABLE 9. MARKET FOR Metal, BY REGION, 2021-2030 (USD Million) TABLE 10. MARKET FOR Polymer, BY REGION, 2021-2030 (USD Million) TABLE 11. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 12. MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 13. MARKET FOR Dermatology, BY REGION, 2021-2030 (USD Million) TABLE 14. MARKET FOR Drug Delivery, BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET FOR Pain Management, BY REGION, 2021-2030 (USD Million) TABLE 16. MARKET FOR Cancer Therapy, BY REGION, 2021-2030 (USD Million) TABLE 17. MARKET FOR Vaccine Delivery, BY REGION, 2021-2030 (USD Million) TABLE 18. MARKET FOR Other, BY REGION, 2021-2030 (USD Million) TABLE 19. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 20. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 21. NORTH AMERICA MARKET, By Type, 2021-2030 (USD Million) TABLE 22. NORTH AMERICA MARKET, By Material, 2021-2030 (USD Million) TABLE 23. NORTH AMERICA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 24. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 25. EUROPE MARKET, By Type, 2021-2030 (USD Million) TABLE 26. EUROPE MARKET, By Material, 2021-2030 (USD Million) TABLE 27. EUROPE MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 28. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 29. ASIA-PACIFIC MARKET, By Type, 2021-2030 (USD Million) TABLE 30. ASIA-PACIFIC MARKET, By Material, 2021-2030 (USD Million) TABLE 31. ASIA-PACIFIC MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 32. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 33. LAMEA MARKET, By Type, 2021-2030 (USD Million) TABLE 34. LAMEA MARKET, By Material, 2021-2030 (USD Million) TABLE 35. LAMEA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 36. AdminMed nanoBioSciences LLC: COMPANY SNAPSHOT TABLE 37. AdminMed nanoBioSciences LLC: OPERATING SEGMENTS TABLE 38. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT TABLE 39. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS TABLE 40. Zosano Pharma Corporation: COMPANY SNAPSHOT TABLE 41. Zosano Pharma Corporation: OPERATING SEGMENTS TABLE 42. RAPHAS CO. LTD: COMPANY SNAPSHOT TABLE 43. RAPHAS CO. LTD: OPERATING SEGMENTS TABLE 44. NANOPASS TECHNOLOGIES LTD : COMPANY SNAPSHOT TABLE 45. NANOPASS TECHNOLOGIES LTD : OPERATING SEGMENTS TABLE 46. Corium International, Inc. (Gurnet Point Capital): COMPANY SNAPSHOT TABLE 47. Corium International, Inc. (Gurnet Point Capital): OPERATING SEGMENTS TABLE 48. Valeritas, Inc. (Zealand Pharma): COMPANY SNAPSHOT TABLE 49. Valeritas, Inc. (Zealand Pharma): OPERATING SEGMENTS TABLE 50. Nitto Denko Corporation: COMPANY SNAPSHOT TABLE 51. Nitto Denko Corporation: OPERATING SEGMENTS TABLE 52. ENDODERMA LTD.: COMPANY SNAPSHOT TABLE 53. ENDODERMA LTD.: OPERATING SEGMENTS TABLE 54. Innoture Medical Technology Limited: COMPANY SNAPSHOT TABLE 55. Innoture Medical Technology Limited: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 10 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2021 Figure 8 Import Data for , By Country, 2016–2021 (USD Thousand) Figure 9 Export Data for , By Country, 2016–2021 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By Material, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Application, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Type, 2019 vs. 2025 (USD Million) Figure 14 Geographical Snapshot of the Market Figure 15 Hollow to Witness Higher CAGR in Market for Type Segment during Forecast Period. Figure 16 Vaccine Delivery to Witness Higher CAGR in Market for Application Segment during Forecast Period. Figure 17 Metal to Witness Higher CAGR in Market for Material Segment during Forecast Period. Figure 18 North America region Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 North America: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview